IMV Inc. Gains 25.77%
Mon, Jul 26, 2021 at 05:33 PM
IMV Inc. (IMV:NASDAQ) soared at $2.05, a gain of 25.8%. The stock got featured on our News Catalysts scanner on Tue, Jul 20, 2021 at 10:31 AM in the 'PUBLIC OFFERING' category. From Fri, Jul 09, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
About IMV Inc. (IMV:NASDAQ)
Immunovaccine Inc is a Canada based clinical-stage biopharmaceutical company. Through its subsidiary, the firm develops T cell activating cancer immunotherapies and infectious disease vaccines based on DepoVax.
Top 10 Gainers:
- BTBT (BTBT:NASDAQ), 109.69%
- The9 Limited (NCTY:NASDAQ), 54.38%
- FLGC (FLGC:NASDAQ), 49.67%
- BITF (BITF:NASDAQ), 31.31%
- Tyme Technologies, Inc. (TYME:NASDAQ), 27.78%
- SPAR Group, Inc. (SGRP:NASDAQ), 27.75%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- MicroStrategy Incorporated (MSTR:NASDAQ), 26.46%
- IMV Inc. (IMV:NASDAQ), 25.77%
- Studio City International Holdings Limited (MSC:NYSE), 22.85%